This move is archived. Current quotes and coverage live on the stock page.
Follow TELY
TelyRx Holdings Inc. shares surged by over 17% in the latest trading session, reflecting strong investor interest.
In a remarkable turn of events, TelyRx Holdings Inc. (TELY.TO) saw its stock price jump by 17.39% in yesterday's trading session, closing at CA$2.70. This surge comes amidst increasing revenues and strategic corporate developments that have caught investors' attention.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$59.30M
52W high
$4.25
52W low
$2.00
1W change
+0.00%
Analyst Price Targets
Based on analyst covering TELY · as of Sep 17, 2026
Wall Street analysts forecast TELY stock price to rise 166.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+166.7% Upside
Current Price
C$2.25
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
69.2%
Annualized
90-Day Vol
95.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.88
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.12 | C$1.67 – C$2.69 |
| 60 trading days | C$2.00 | C$1.43 – C$2.80 |
| 90 trading days | C$1.88 | C$1.24 – C$2.85 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the potential for growth in TelyRx Holdings, especially given its recent financial performance and market positioning.
TelyRx Holdings Inc. Sees 17.39% Surge in Stock Price
The stock's impressive rise reflects growing investor confidence in TelyRx's business model and future prospects.
Bull case
TelyRx's recent financial results show a significant revenue increase, indicating that the company is on a growth path. This could attract investors looking for opportunities in the healthcare sector.
Bear case
Despite the positive movement, TelyRx still faces challenges, including a net loss reported in its latest financial results. This may raise concerns about its profitability in the near term.
Financial Performance Highlights
Advertisement
TelyRx reported a remarkable revenue increase to CA$19.4 million for Q1 2026, up from CA$6.9 million in the same quarter last year. This growth highlights the company's potential in the healthcare sector, despite a net loss of CA$4.7 million.
Market Reaction and Investor Sentiment
The stock's surge reflects a positive market reaction to TelyRx's recent developments, including its name change and trading commencement on the TSX. Investors are showing increased interest, likely driven by the company's growth narrative.
Looking Ahead
As TelyRx continues to navigate its growth path, investors should keep an eye on upcoming financial results and market strategies. For more insights on TelyRx Holdings Inc., visit our stock page for detailed analysis and updates.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
